Company
Prelude Therapeutics
- Business model
- B2B
Claim, correct or request removal
Record updated 4 October 2026
About
Prelude Therapeutics is a leading precision oncology company developing innovative medicines in areas of high unmet need for cancer patients. Our pipeline features highly selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors – new approaches to clinically validated targets with transformative potential for patients. We are also leveraging our expertise in targeted protein degradation to […]
Loading relationship preview